MedPath

Effects of wet cupping therapy in non-alcoholic fatty liver disease

Not Applicable
Conditions
on-alcoholic fatty liver disease (NAFLD).
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20220425054654N1
Lead Sponsor
Iran's National Elites Foundation (INEF)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Men and women affected by non alcoholic fatty liver disease grade II and III proved by ultrasonography of the liver
NAFLD patients with or without alteration in their liver enzymes

Exclusion Criteria

Patients who were affected by other chronic liver diseases or hepatitis and anemia
Heavy smokers
Alcohol drinkers with intake greater than 2 alcohol units (20 g/day) for women and greater than three alcohol units (30 g/day) for men
Patients with prolonged intake of drugs induced fatty liver diseases such as amiodarone, perhexiline, DH, steroid hormones, tamoxifen and ...

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath